A cost-of-illness study of Behçet syndrome in Italy.

Eur J Health Econ

Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, University of Pisa, Pisa, Italy.

Published: April 2024


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective: This study aims at evaluating the cost-of-illness (COI) of patients diagnosed with Behcet's syndrome (BS) in Italy, trying to depict the impact of different costs' components to the overall economic burden and analysing the variability of costs according to years since diagnosis and age at first symptoms.

Methods: With a cross-sectional evaluation, we surveyed a large sample of BS patients in Italy assessing several dimensions related to BS, also including fact related to the use of health resources utilization, formal and informal care, and productivity losses. Overall costs, direct health, direct non-health, and indirect costs were thus estimated per patient/year considering a Societal perspective and the impact of years since diagnosis, age at first symptoms on costs was evaluated using generalized linear model (GLM) and a two-part model, adjusting for age and distinguishing among employed and non-employed responders.

Results: A total of 207 patients were considered in the present study. From the perspective of the Society, mean overall costs for BS patient were estimated to be 21,624 € (0;193,617) per patient/year. Direct non-health expenses were the main costs component accounting for 58% of the overall costs, followed direct health costs, 36%, while indirect costs because of productivity losses represented 6% of the overall costs. Being employed resulted in significantly lower overall costs (p = 0.006). Results from the multivariate regression analyses suggested that the probability of incurring in overall costs equal to zero decreased as time from BS diagnosis is 1 year or more as compared to newly diagnosed patients (p < 0.001); while among those incurring in expenses, costs decreased for those experiencing first symptoms between 21 and 30 years (p = 0.027) or later (p = 0.032) as compared to those having symptoms earlier. Similar findings emerged among the subgroups of patients declaring themselves as workers, while no impact of years since diagnosis or age of first symptoms was found among non-workers.

Conclusions: The present study offers a comprehensive overview of the economic consequences imposed by BS in a societal perspective, providing insights into the distribution of the different costs component related to BS, thus helping the development of targeted policies.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10973046PMC
http://dx.doi.org/10.1007/s10198-023-01593-8DOI Listing

Publication Analysis

Top Keywords

costs
12
syndrome italy
8
years diagnosis
8
diagnosis age
8
productivity losses
8
costs direct
8
direct health
8
direct non-health
8
indirect costs
8
cost-of-illness study
4

Similar Publications

Purpose: The fourth phase of the Electronic Medical Records and Genome Network (eMERGE4) is testing the return of 10 polygenic risk scores (PRS) across multiple clinics. Understanding the perspectives of health-system leaders and frontline clinicians can inform plans for implementation of PRS.

Methods: Fifteen health-system leaders and 20 primary care providers (PCPs) took part in semi-structured interviews.

View Article and Find Full Text PDF

Aims: The increasing antimicrobial resistance, particularly in Acinetobacter baumannii, complicates the treatment of infections, leading to higher morbidity, mortality, and economic costs. Herein, we aimed to determine the in vitro antimicrobial, synergistic, and antibiofilm activities of colistin (COL), meropenem, and ciprofloxacin antibiotics, and curcumin, punicalagin, geraniol (GER), and linalool (LIN) plant-active ingredients alone and in combination against 31 multidrug-resistant (MDR) A. baumannii clinical isolates.

View Article and Find Full Text PDF

Introduction: Surgical training is expensive. The aim of this study was to quantify the costs surgical trainees are expected to pay related to the ten surgical specialties in a single Statutory Education Body (SEB).

Methods: Intercollegiate Surgical Curriculum Programme (ISCP) and Joint Committee on Surgical Training (JCST) certification requirements including mandatory and highly recommended courses, related to specialty, along with professional registration and examination fees were estimated.

View Article and Find Full Text PDF

In the US, there has historically been strong public opposition to health-care reform involving "socialized medicine." This resistance, at least in part, is influenced by a deeply entrenched individualistic ethos. It is becoming increasingly clear, however, that the current US health-care system is broken, and that existing systems around the world achieve better outcomes while costing less.

View Article and Find Full Text PDF

Methods used in early value assessments for nice: a scoping review.

Int J Technol Assess Health Care

September 2025

Evidence Synthesis Group, Population Health Sciences Institute, Faculty of Medical Sciences, https://ror.org/01kj2bm70Newcastle University, Newcastle upon Tyne, UK.

Objectives: The National Institute for Health and Care Excellence (NICE) in England introduced early value assessments (EVAs) as an evidence-based method of accelerating access to promising health technologies that could address unmet needs and contribute to the National Health Service's Long Term Plan. However, there are currently no published works considering differences and commonalities in methods used between Assessment Reports for EVAs.

Methods: This rapid scoping review included all completed EVAs published on the NICE website up to 23 July 2024.

View Article and Find Full Text PDF